Werner H, Hohlfeld P, Jacquemard F, Mirlesse V, Menez D, Daffos F
Centre de Diagnostic Prénatal, Institut de Puériculture de Paris.
J Gynecol Obstet Biol Reprod (Paris). 1994;23(6):701-5.
Describe our experience with the RU 486 (mifepristone) in case of pregnancy termination induced by sulprostone.
Prospective non controlled study in the department of Fetal Medicine of the "Institut de Puériculture de Paris". 158 women undergoing termination of pregnancy during the second and third trimester received a single dose of 600 mg of RU 486, 36 hours prior to infusion of 100 micrograms/hour of sulprostone.
Delay between sulprostone therapy and diagnosis of labour duration of delivery. Prostaglandin doses used and frequency of secondary effects.
The mean time between sulprostone administration and diagnosis of labour (146.5 +/- 106 minutes) as well delay of delivery (592.2 +/- 504 minutes) corresponded to the results reported in the literature. The primigravid women needed higher doses of prostaglandin and consequently experienced more secondary effects. No severe secondary effects were observed in this study.
RU 486 is a satisfactory treatment for pregnancy termination during the second or third trimester.
描述我们使用RU 486(米非司酮)进行磺前列酮引产的经验。
在“巴黎妇幼保健院”胎儿医学科进行前瞻性非对照研究。158名在妊娠中期和晚期接受引产的妇女在输注每小时100微克磺前列酮前36小时接受600毫克RU 486单剂量治疗。
磺前列酮治疗至分娩诊断的间隔时间、分娩持续时间。使用的前列腺素剂量和副作用发生频率。
磺前列酮给药至分娩诊断的平均时间(146.5±106分钟)以及分娩延迟时间(592.2±504分钟)与文献报道结果相符。初产妇需要更高剂量的前列腺素,因此副作用更多。本研究中未观察到严重副作用。
RU 486是妊娠中期或晚期引产的一种满意治疗方法。